Name: Stem Cell Therapy: An Emerging Modality in Glomerular Diseases (Omn. Univ. Europ. ) (en Francés)
SKU: 48910067
Price: 827.42 MXN
Availability: InStock
Author: Umang Thakkar
ISBN: 9783330869264

portada Stem Cell Therapy: An Emerging Modality in Glomerular Diseases (Omn. Univ. Europ. ) (en Francés)

Stem Cell Therapy: An Emerging Modality in Glomerular Diseases (Omn. Univ. Europ. ) (en Francés)

Formato

Libro Físico

Editorial

Univ Européenne

Autor

Umang Thakkar

Año

2017

Idioma

Francés

N° páginas

Encuadernación

Tapa Blanda

ISBN13

9783330869264

Stem Cell Therapy: An Emerging Modality in Glomerular Diseases (Omn. Univ. Europ. ) (en Francés)

Umang Thakkar (Autor) · Univ Européenne · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

$ 1,504.39$ 827.42

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 827.42

¡Envío Gratis! Llega entre el 16 Oct y el 26 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Stem Cell Therapy: An Emerging Modality in Glomerular Diseases (Omn. Univ. Europ. ) (en Francés)"

In the human body kidney is one special organ which is highly terminally differentiated and has very limited capacity to regenerate following injury/ insult. Hence once glomerular diseases set in, they usually progress to end-stage renal disease (ESRD) requiring dialysis or renal transplantation (RT) for better quality of life. However shortage of implantable kidneys and complications of transplantation like immune rejection immunosuppression related morbidity/ mortality, including immunocompromised status, metabolic disorders, infections and malignancies, RT remains a challenge. Therapeutic options available for management of glomerular diseases include symptomatic treatment strategies to delay progression to ESRD. Stem cell-based therapy (SCT) forms recent innovative therapeutic modalities for such diseases due to its ability to inhibit inflammation, replenish dying tissues/ cells and promote regeneration. This review focuses on SCT for treatment of glomerular diseases, including various cell sources used and recent advances in preclinical and clinical studies.